Univercells: Funding, Investors & Team (Oct 2026)
Univercells has raised $43.0M across 1 funding round on record, the most recent a Series D of $43.0M announced in Oct 2022.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Univercells Company Profile and Key Stats
Latest funding round on record: Oct 2022.
Univercells Funding Rounds
Univercells Founders and Leadership Team
No contact details are on record for this team yet.
Univercells Funding Compared to Other Biotechnology Startups
Univercells' latest round of $43.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Univercells in Biotechnology and Gosselies
Companies Similar to Univercells
Turning biomass residues into fit-for-purpose microbial fertilizers, biostimulants and biocontrols.
A biopharmaceutical business called Novadip Biosciences was established with the goal of creating,…
Amyl therapeutics is a preclinical-stage biotechnology company pioneering a breakthrough approach to treating…
MAASH is a biotech mycoprotein producing company that supply a nutritious and health feed and food protein…
Nyxoah is a health-technology company focused on the development and commercialization of innovative…
Coultreon Biopharma is developing best-in-class therapeutics that target clinically validated pathways in…
neuroClues provides easy-to-use eye-tracking environment to help practitioners instantaneously quantify their…
Trince is advancing cell-based science and therapeutics by facilitating the delivery of molecules into cells,…
Confo Therapeutics is a company focused on drug discovery, specifically targeting GPCRs to address medical…
Animab is a biotech company that focuses on developing unique technology to enhance the health of livestock.…
Augustine Therapeutics company is conducting two drug discovery programs in order to discover new generations…
4Tissue is a company focused on research and clinical trials that creates remedies to address the challenges…
Univercells Funding FAQs
How much funding has Univercells raised?
Univercells has raised $43.0M across 1 round on record. The most recent is a Series D of $43.0M announced in Oct 2022.
When did Univercells last raise funding?
Univercells' most recent funding round on record is a Series D of $43.0M, announced in Oct 2022.
Who is the CEO of Univercells?
Hugues Bultot is listed as CEO at Univercells.
Where is Univercells headquartered?
Univercells is based in Gosselies, Hainaut, Belgium.
How many employees does Univercells have?
Univercells is in the 101-250 employee band.
How does Univercells' funding compare to other Biotechnology startups?
Univercells' latest round of $43.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Univercells Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Univercells is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.